Secure your spot at Vitalist Bay

Tim Urban is an author, speaker, and popular blogger best known for his blog, "Wait But Why." He is renowned for his engaging long-form articles and stick-figure illustrations that cover a wide range of topics, from procrastination to artificial intelligence. Tim graduated cum laude from Harvard University with a degree in Government and has co-founded several successful ventures, including ArborBridge and truePrep. His unique blend of humor and insight has earned him a large following and recognition as one of the internet's most captivating writers.

Kristen Fortney is the co-founder and CEO of BioAge Labs, a computational biology startup in Berkeley, California. She received her PhD in Medical Biophysics from the University of Toronto and completed her postdoctoral training at Stanford University. Kristen is an expert in developing bioinformatics approaches to investigate aging and age-related diseases. Her research focuses on computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity. As CEO, she leads BioAge Labs in its mission to develop therapies that target aging to increase healthspan and address chronic diseases.

Peter Diamandis is a visionary entrepreneur, physician, and author, best known as the founder and executive chairman of the XPRIZE Foundation, which designs and operates large-scale incentive competitions to solve global challenges. He is also the executive founder of Singularity University, a Silicon Valley institution focused on exponentially growing technologies. With degrees in molecular genetics and aerospace engineering from MIT and an M.D. from Harvard Medical School, Diamandis has founded over 25 companies in fields such as health-tech, space, and education. He is a New York Times bestselling author and a recognized leader, named by Fortune as one of the "World's 50 Greatest Leaders".

Matt Kaeberlein, PhD, is the CEO of Optispan, driving innovation in predictive, preventive, and personalized healthcare. A renowned expert in aging biology, he is also a professor at the University of Washington, where he has made significant contributions to the field of oral health sciences, pathology, and genome sciences. Kaeberlein co-directs the Dog Aging Project and serves as CEO of the American Aging Association. His research on longevity and aging has earned international recognition, and he has been a leader in advancing medical solutions to extend healthy human lifespans.

Omri Amriav-Drory is a scientist and entrepreneur, currently serving as the General Partner at NFX Bio. He is the Founder and CEO of Renewal Bio, a company focused on developing innovative solutions in the field of biotechnology. Omri previously founded Genome Compiler, which was acquired by Twist Bioscience, and has played a pivotal role in scaling and investing in influential techbio companies. His unique blend of scientific expertise and entrepreneurial experience makes him a significant figure in the techbio industry.

Adam Bataineh is a medical doctor and the founder of Numenor, an online longevity clinic based in London. He is dedicated to making cutting-edge health interventions accessible to everyone, with a focus on personalized, preventative healthcare. Adam's work at Numenor aims to extend healthspan by targeting key biomarkers associated with aging-related diseases and providing comprehensive health assessments and personalized treatment plans. His belief in the urgent need to address aging drives his mission to bring longevity medicine to a wider audience.

Robin Hanson is an associate professor of economics at George Mason University and a research associate at the Future of Humanity Institute at Oxford University. He is known for his pioneering work on prediction markets, also known as idea futures, and has been a key figure in developing these markets for various applications. Robin has authored several influential books, including "The Age of Em: Work, Love and Life When Robots Rule the Earth" and "The Elephant in the Brain: Hidden Motives in Everyday Life." His research spans a wide range of topics, from spatial product competition to the bioethics of healthcare, and he is a prominent advocate for futarchy, a form of governance based on prediction markets.

Joe Betts-LaCroix is an American scientist and entrepreneur known for his discoveries in biophysics and for creating the world's smallest personal computer. He is currently the co-founder and CEO of Retro Biosciences, a company focused on developing therapeutics to increase healthy human lifespan by ten years. Joe has a background in earth sciences, biophysics, and computer hardware, and has contributed to significant advancements in both scientific research and technology innovation.

David Barzilai is a physician, longevity consultant, and health coach, known for his expertise in geroscience and longevity medicine. As the founder and CEO of Healthspan Coaching LLC, he provides personalized health and longevity coaching, integrating the latest scientific research and technology. David is also an active member of the longevity community, engaging with scholars and practitioners on social media under the handle @agingdoc1. His work focuses on promoting healthy aging and optimizing healthspan through evidence-based practices and lifestyle interventions.

Allison Duettmann is the President and CEO of the Foresight Institute, where she directs programs on Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs. She is also the Founder of Existential Hope and has co-edited works on superintelligence and co-authored books on future technologies. Allison holds an MS in Philosophy & Public Policy from the London School of Economics, focusing on AI Safety. She is a prominent advocate for leveraging technology to create a positive long-term future for humanity.

Brian Kennedy is a scientist and entrepreneur, known for his significant contributions to the field of aging research. He has held leadership positions at several prominent institutions, including the Buck Institute for Research on Aging, where he served as President and CEO. Brian's work focuses on understanding the mechanisms of aging and developing interventions to promote healthy longevity. His research has been instrumental in advancing the field of biogerontology and has garnered widespread recognition.

Chris Mirabile is the Founder and CEO of NOVOS, a pioneering consumer longevity biotech company dedicated to addressing the mechanisms of aging. Overcoming a brain tumor at a young age, Chris has devoted his life to health and longevity, achieving a biological age significantly younger than his chronological age through a balanced lifestyle and innovative health practices. He has been featured in numerous publications and has spoken at various conferences about his journey and the science behind slowing aging. Chris is passionate about making longevity achievable and accessible for all through scientifically validated, over-the-counter formulations and best-in-class biological age tests.

Vincent Weisser is a dedicated advocate for decentralized science and AI, known for his work on projects like VitaDAO, which funds longevity research, and Molecule, a platform for scientific funding. He is passionate about democratizing access to cutting-edge technologies and scientific progress, aiming to create a future where advanced AI and biotechnology are accessible to all. Vincent's diverse interests and contributions span across AI, biotechnology, energy, and more, making him a key figure in the tech and science communities.

Anastasiya Giarletta is a prominent figure in the longevity and biotech sectors, serving as an advisor and co-founder of Aikora Health and an investor at R42 Group. Based in Silicon Valley and London, she focuses on connecting venture funds, angels, and entrepreneurs within the early-stage longevity ecosystem. Anastasiya is also a Teaching Assistant at Stanford University School of Medicine, where she lectures on Longevity Venture Capital and Healthcare Venture Capital. Her extensive network and expertise make her a key influencer in advancing healthcare and human aging technologies.

Phil Newman is the Founder and CEO of Longevity.Technology, a leading media and investment platform focused on the longevity megatrend. He has held multiple C-level management positions, applying his marketing and business development expertise in sectors such as longevity, IoT, bionics, medical devices, biopharma, and 3D manufacturing. Phil's work aims to bring together innovators and investors to commercialize companies that will form the longevity economy.

Daniel Ives is the CEO and founder of Shift Bioscience, a company dedicated to reversing cellular aging using AI-guided cellular rejuvenation techniques. With a background in mitochondrial biology from the University of Cambridge, Daniel has been at the forefront of developing innovative solutions to combat age-related diseases. His work focuses on leveraging advanced machine learning and epigenetic aging clocks to discover new therapeutic interventions that can extend human healthspan.

Dr. Emil Kendziorra is the Founder and CEO of Tomorrow.Bio, a startup dedicated to advancing biostasis (cryonics) research and providing human cryopreservation services. He graduated summa cum laude from the University of Göttingen and has extensive experience in cancer research and entrepreneurship. Dr. Kendziorra has founded and led multiple tech and medical startups, including MedLanes and onFeedback. His vision is to build an organization that significantly contributes to the field of cryonics and promotes public awareness about its potential.

Andrew Steele is a scientist, writer, and campaigner based in Berlin. He holds a PhD in physics from the University of Oxford and has transitioned to computational biology, focusing on aging research. Andrew is the author of "Ageless: The New Science of Getting Older Without Getting Old" and regularly contributes to major publications like the Wall Street Journal and WIRED. He is also a popular science presenter on television and YouTube, making complex scientific concepts accessible to a broad audience.

Nils Regge is a serial entrepreneur and investor with a strong passion for health and biotechnology. He is the co-founder and Managing Director of Apollo Health Ventures, a venture capital fund focused on aging and age-related diseases. Nils has founded several successful companies, including TruVenturo and HomeToGo, and has been involved in numerous financing rounds. His expertise in growing early-stage startups and his commitment to advancing biomedicine make him a key player in the longevity sector.

Kai Micah Mills is the CEO of Cryopets, a startup specializing in cryopreservation for pets, and a co-founder of CryoDAO, a decentralized organization funding cryonics research. With a background as a tech entrepreneur and Thiel Fellow, Kai is dedicated to advancing cryopreservation technologies and making significant contributions to the field of life extension.

Clara Fernandez Porta is a visionary leader and innovator in the field of longevity, known for her roles as the CEO and co-founder of RxLongevity and the founder of Europe's largest Longevity Clinic for Seniors. She has been recognized as one of the Top 100 Female Leaders and Top 100 Forbes Creatives in Spain, and is also a celebrated author with Penguin Editorial, contributing significantly to the discourse on healthy aging and longevity. Her work focuses on empowering seniors to live longer, healthier lives through personalized health plans and cutting-edge technology.

Karl Pfleger is a prominent angel investor and advocate for longevity research, known for his significant contributions to the biotech industry. He is an investor in Repair Biotechnologies, focusing on gene therapy for age-related diseases, and runs Aging Biotech Info, a valuable resource for the longevity community. Karl's background in machine learning and his dedication to supporting groundbreaking research make him a key figure in the fight against aging.

Alfredo Andere is the co-founder and CEO of LatchBio, a platform that provides biology companies with the tools to store, transform, and analyze large data sets. Before founding LatchBio, he worked as a Data Engineer at Facebook and a Software Engineer at Google Brain, gaining valuable experience in handling large-scale data. Alfredo and his co-founders envisioned bringing high-quality computational infrastructure to the field of biology, and they dropped out of their senior year at UC Berkeley to pursue this goal. Since its inception, LatchBio has raised significant funding and serves numerous biotech companies.

Ole Mensching, Ph.D., is the co-founder and General Partner of Apollo Ventures, a venture capital fund dedicated to aging and age-related diseases. He has a strong background in investment and operations, previously co-founding CareerTeam, a successful headhunting agency. Ole holds a Ph.D. from the University of California, Berkeley, and the University of Cologne, and his expertise in HR and team building has been instrumental in supporting Apollo's portfolio companies.

Matthew Scholz is the Founder and Chief Executive Officer of Oisín Biotechnologies, a company pioneering gene therapy to target senescent cells and combat age-related diseases. He previously co-founded Immusoft and has been instrumental in developing innovative biotechnological solutions. Matthew's work focuses on creating therapies that can extend healthy lifespan and improve quality of life. His vision and leadership in the field of biotechnology make him a significant figure in the quest for longevity and healthspan enhancement.

Laurence Ion is a longevity advocate, entrepreneur, and investor dedicated to bringing aging under medical control. As the Founding Steward and Strategy Advisor at VitaDAO, he focuses on funding aging research projects and spinning out longevity biotech startups. Laurence is also the Co-initiator of Vitalia.city, a decentralized city aimed at accelerating drug development, and a Core member at JellyfishDAO, where he helps create inspiring content about longevity. His work aims to extend healthy lifespans through innovative and collaborative approaches.

Jean Hebert is a distinguished scientist and entrepreneur, currently serving as a Program Manager at ARPA-H, where he focuses on health science futures. He previously held faculty positions at the Albert Einstein College of Medicine, specializing in genetics and neuroscience. Jean is the founder of BE Therapeutics, a company dedicated to reversing age-related damage to brain tissue. His research explores stem cell transplantation, neurodegeneration, and cortical health, aiming to develop regenerative therapies for aging tissues.

Laura Minquini is a longevity and women's health entrepreneur, known for her work in branding and luxury design. She has collaborated with prestigious companies such as Louis Vuitton, Apple, and Amazon. Laura is the founder of MYKIGAI, a discovery and recommendation platform for longevity, and the core lead of AthenaDAO, a decentralized collective funding women's health research. Her mission is to leverage her expertise to make science work for women, promoting healthier aging and well-being.

Dylan Livingston is the Founder and President of the Alliance for Longevity Initiatives (A4LI), a non-profit organization focused on advocating for policies that promote healthy human lifespan. He has a background in grassroots political organizing and has worked with various political campaigns, including the Biden campaign in Pennsylvania. Dylan is passionate about increasing equitable access to next-generation therapies and has been involved in the longevity community since childhood, influenced by his father's early-stage investments in futuristic technologies.

Sebastian Brunemeier is a biotech venture capitalist and company builder focused on longevity and regenerative medicine. He is the co-founder and General Partner of Healthspan Capital and the CEO and founder of ImmuneAGE Bio, a company dedicated to immune system rejuvenation. Sebastian has co-founded several longevity biotech companies, contributing to significant advancements in the field. His extensive experience and dedication to improving human healthspan have made him a respected figure in the biotech industry.

David Gobel is a philanthropist, entrepreneur, inventor, and futurist, best known for co-founding the Methuselah Foundation, which focuses on extending healthy human lifespans through regenerative medicine and biotechnology. He has been a driving force in promoting the concept of longevity escape velocity and has supported numerous projects and companies aimed at combating age-related diseases. David's visionary work continues to inspire advancements in the field of life extension.

Patri Friedman is a prominent libertarian and anarcho-capitalist, known for founding The Seasteading Institute, which explores the creation of sovereign ocean colonies. He is also the General Partner at Pronomos Capital, a venture capital firm focused on developing experimental cities in developing countries. Patri's innovative approaches to governance and urban development continue to inspire discussions on alternative political and social systems.

Adam Gries is a serial entrepreneur with 16 years of experience building and scaling consumer software. He has founded and sold five companies, including products that reached over 30M monthly active users. His ventures span gaming, social media, fashion ecommerce, and mobile edtech, where he’s excelled as a product-driven, technical CEO. In recent years, Adam has focused on longevity as an angel investor (Loyal, NOVOS), mentor (Harvard Innovation Labs), and influencer. He co-founded vitalism.io, runs longevitystate.com, and launched Tokyo Longevity Summit. A dedicated biohacker, Adam built his own elite health optimization playbook.

Mark Lutter is the Founder and Executive Chairman of the Charter Cities Institute, a nonprofit organization dedicated to building the ecosystem for charter cities. He is also the CEO of Braavos Cities, a charter city development company. With a PhD in economics from George Mason University, Mark's work focuses on innovative governance and economic development through the creation of new cities. His vision is to demonstrate better governance mechanisms and attract talent to these new urban centers.

Anar Isman is the co-founder and CEO of AgelessRx, a telemedicine platform dedicated to slowing down the aging process through scientifically-backed interventions. With a background in investment management, Anar transitioned to the field of longevity science driven by a desire to make a meaningful impact on human health. He believes in making cutting-edge longevity treatments accessible to everyone and is passionate about advancing the field to help people live healthier, longer lives.

Virginia Gambardella is the founder of Anapana and co-host of the Tressessanta podcast, ranked among Italy's top 100. She is passionate about building communities around mental and physical well-being, having grown a community of 300K across social media platforms. With a background in strategy and operations, Virginia has worked at McKinsey & Company and Serenis, where she led operations. Her entrepreneurial journey includes founding Moebius Milano and buoono.farm. A Bocconi graduate, she brings a unique mix of academic excellence and hands-on experience in diverse sectors.

Aykut Karaalioglu is an accomplished entrepreneur and investor, best known for founding MobileAction, a company specializing in app discovery and optimization. He has held various leadership roles, including CEO of SearchAds.comand Growth Lead at ScoreBeyond. Aykut is also an active angel investor and advisor to several startups, leveraging his extensive experience in product management and user acquisition to drive innovation and growth in the tech industry.

Geoffrey Miller, PhD, is a renowned professor of evolutionary psychology at the University of New Mexico and a Stanford alumnus. An expert in sexual selection and human behavior, he has authored influential books shaping the field. A key figure in the Effective Altruism movement, Miller focuses on AI safety, existential risks, and mitigating global catastrophic threats to align artificial intelligence with human values. As a consultant, he applies evolutionary psychology to consumer behavior and market research, bridging academic insights with practical applications to drive innovation and societal impact.

Matthew "Oki" O'Connor is the Co-CEO of Cyclarity Therapeutics, a company focused on developing treatments for cardiovascular diseases through innovative cyclodextrin technology. With a Ph.D. in Biochemistry and extensive research experience in aging and regenerative medicine, O'Connor has made significant contributions to the field. His work aims to eliminate toxic oxidized cholesterol, a major factor in atherosclerosis, and improve overall healthspan.

Christine Peterson is a visionary leader and advocate for emerging technologies, best known for co-founding the Foresight Institute, which focuses on nanotechnology and its long-term impacts. She is credited with coining the term "open source software," highlighting her influence on both technology and intellectual property. Christine is also an author and lecturer, sharing her insights on nanotechnology, AI, and longevity to educate the public and policymakers about the potential of these transformative fields.

Mac Davis is the founder of Minicircle, a pioneering company focused on revolutionizing gene therapy. With a mission to enhance human health and sovereignty, he developed a reversible human genetic enhancement protocol that uses non-inflammatory, non-heritable plasmids to safely introduce genes into the body without altering the genome. Mac’s innovative approach challenges traditional medical practices, offering a fast, accessible, and ethical alternative to lifelong treatments. His work aims to empower individuals and communities, ensuring that gene therapy is available to all, free from the constraints of the current healthcare system.

John Davis is a philosopher and author, best known for his work "New Methuselahs: The Ethics of Life Extension." In this book, Davis explores the ethical implications of extending human life, addressing issues such as desirability, unequal access, and potential overpopulation. His philosophical discussions provide a comprehensive guide to the ethical considerations of life extension, making a compelling case for funding research in this field.

Joseph Everett, also known as WIL, is the creator of the popular YouTube channel "What I've Learned." His content focuses on connecting the dots, making conclusions, and weighing them against modern dogma. Joseph covers a wide range of topics, including health, productivity, cognitive enhancement, and general self-improvement. His goal is to provide viewers with actionable takeaways that can be applied to daily life. Joseph's work is appreciated for its insightful and evidence-based approach to complex subjects.

Breanna Deutsch is a policy expert and author, known for her work in political communications and advocacy for life extension technologies. She is the Secretary of the Board at A4LI and the author of "Finding the Fountain: Why Government Must Unlock Biotech's Potential to Maximize Longevity." Breanna's efforts focus on encouraging policymakers to support aging research and promote healthier lifespans through government initiatives.

Patrick Linden is a philosopher and author, known for his work on the ethics of life extension and the philosophy of death. He has taught at various prestigious institutions, including Lund University, UCL, and NYU. His book, "The Case Against Death," argues that death is an evil that should be combated through anti-aging science and radical life extension. Linden's work challenges traditional views on mortality and advocates for a future where humans can live significantly longer, healthier lives.

Derya Unutmaz, MD, is a distinguished professor at The Jackson Laboratory, renowned for his pioneering work on human T cell differentiation, activation, and regulation in immunity, diseases, and aging. With a medical degree from Marmara University, Istanbul, he also holds a concurrent professorship at the University of Connecticut Health Center. Dr. Unutmaz’s research has transformed understanding of T cell dysfunction in diseases like HIV and chronic fatigue syndrome. His work aims to optimize immune responses and develop therapies that combat age-related diseases, advancing healthier aging and immune system treatments.

Jun Axup is a biotechnologist and entrepreneur, currently serving as the Chief Operating Officer at E11 Bio, a non-profit focused on building high-throughput molecular tools to map the brain connectome. She previously held the position of Chief Science Officer and Partner at IndieBio, where she funded and advised over 160 companies working on improving human and planetary health. Jun holds a PhD in chemical biology from the Scripps Research Institute and has co-founded multiple startups in fields such as immuno-oncology, protein engineering, and lab automation robotics. Her passion for brain longevity and innovative biotechnological solutions drives her work.

Andrew Brack is a distinguished scientist and entrepreneur, currently serving as the Program Manager for Proactive Health at ARPA-H. He previously co-founded Arrive Bio, a biotechnology company that uses machine learning to identify drugs for age-related diseases. Andrew has a Ph.D. in molecular biology and biophysics from King’s College London and has held faculty positions at UCSF and Stanford University. His research focuses on the cellular and molecular mechanisms of skeletal muscle repair during aging.

Adeel Khan is a Canadian Board Certified Physician and a leading figure in regenerative medicine and longevity. As the founder of Eterna Health Clinics, he is recognized for his innovative work in stem cell therapy and anti-aging treatments. Dr. Khan has gained global recognition for treating high-profile clients, including celebrities and elite athletes. His dedication to advancing regenerative medicine and improving health outcomes has made him a respected name in the field.

Marco Quarta is a distinguished scientist and entrepreneur, currently serving as the Co-founder, President & CSO of Rubedo Life Sciences. He holds a Ph.D. in Neuroscience from the University of Padua and has conducted post-doctoral research in aging and stem cell biology at Stanford University. Marco has over 20 years of experience in the fields of aging, stem cells, and regenerative medicine, and has co-founded several biotech companies. His work focuses on developing treatments for age-related diseases and extending healthspan by targeting pathological cells involved in the aging process.

Parmita Mishra is a computational biologist and entrepreneur, known for founding Precigenetics, a company focused on developing advanced non-invasive diagnostic tools that integrate biophotonics with machine learning. She is dedicated to pushing the boundaries of healthcare technology, particularly in the field of non-invasive cancer diagnostics. Parmita's work aims to enhance the identification of molecular signatures unique to cancerous cells, leveraging machine learning algorithms to improve detection and classification.

Morten Scheibye-Knudsen is an associate professor at the University of Copenhagen, where he leads the Scheibye-Knudsen Group. His research focuses on understanding the cellular and organismal consequences of DNA damage, with the goal of developing interventions to combat age-related diseases such as Alzheimer's and Parkinson's. Morten's work has shown that replenishing certain metabolites altered by DNA damage can influence the aging process in model organisms, suggesting potential therapeutic approaches for healthier aging.

Max More is a philosopher and futurist known for his work on transhumanism and the philosophy of extropy. He is the founder of the Extropy Institute and has served as President and CEO of the Alcor Life Extension Foundation. Max holds a degree in Philosophy, Politics, and Economics from Oxford University and a PhD in Philosophy from the University of Southern California. His writings and ideas have significantly influenced the transhumanist movement, focusing on the potential of emerging technologies to enhance human capabilities and extend life.

Mahdi Moqri, Ph.D., is a Harvard Faculty member, computational biologist, and the founding director of the Biomarkers of Aging Consortium. His interdisciplinary expertise spans omics, bioinformatics, and computational methods to explore the molecular mechanisms of aging and develop innovative therapies for age-related diseases. As director, he leads international collaborations to validate blood-based biomarkers of aging, with research published in Cell and Nature Medicine. Previously, Dr. Moqri completed a postdoctoral fellowship at Stanford University and has raised over $1M to advance aging research. He is passionate about enhancing human health and longevity.

Eli Mohamad is a serial entrepreneur and scientist, currently serving as an Entrepreneur in Residence at Narwhal Sciences, where he is incubating the Fraktus Protocol. He is a core team member of CryoDAO, focusing on advancing cryopreservation research, and has co-founded several organizations, including X-Therma and the Organ Preservation Alliance. Eli's work spans various cutting-edge fields, from tissue preservation to decentralized science, showcasing his commitment to innovation and scientific progress.

Reason is the co-founder and CEO of Repair Biotechnologies, pioneering solutions to combat aging and extend human healthspan. An active angel investor in the longevity sector, he has backed companies like Oisin Biotechnologies and Leucadia Therapeutics. As a passionate patient advocate, Reason supports fundraising and outreach efforts for organizations like the Methuselah Foundation and SENS Research Foundation. He is also the founder and writer of Fight Aging!, a prominent biotechnology news and commentary platform. Before his biotechnology career, Reason was a consultant in the software industry.

Arkadi Mazin is a seasoned journalist and op-ed author with a passion for learning and exploration. His interests span from politics to science and philosophy. Having studied economics and international relations, he is particularly interested in the social aspects of longevity and life extension. Arkadi is dedicated to promoting the idea that life extension is an achievable and noble goal that deserves greater attention and action from society.

Hugo Bailly is the co-founder of Erectus DAO, a decentralized autonomous organization focused on advancing regenerative medicine and stem cell therapies. With a background in urology and extensive research experience, Hugo is dedicated to exploring innovative treatments for conditions such as erectile dysfunction and Peyronie's disease. His work aims to harness the potential of stem cells to improve patient outcomes and promote overall health.

Jason Sorens is an American political scientist and conservative libertarian activist, best known for founding the Free State Project in 2001. He holds a PhD in political science from Yale University and a BA in economics and philosophy from Washington and Lee University. Jason has taught at several prestigious institutions, including Yale, Dartmouth, and the University at Buffalo. His research focuses on fiscal federalism, public policy in federal systems, secessionism, and ethnic politics. He is also a Senior Research Fellow at the American Institute for Economic Research (AIER) and president of the Ethics and Economics Education of New England (E3NE).

Andrew Verbinnen is a co-founder of HairDAO, a decentralized science (DeSci) project aimed at tackling hair loss through innovative funding and research models. With a background in Government from Hamilton College and experience in private equity and cryptocurrency, Andrew transitioned to the DeSci space to address the misaligned incentives in pharmaceutical research. His work focuses on leveraging blockchain technology to democratize early-stage research and improve patient outcomes.

Gennady Stolyarov II is a Belarusian-American libertarian and transhumanist writer, actuary, and civil servant. He is best known for his book "Death is Wrong," which argues that death is an enemy to be overcome through technology. Gennady is also the Chairman of the Transhumanist Party, advocating for life extension and the use of science and technology to enhance human capabilities.

Ronjon Nag is a British-American inventor, entrepreneur, and educator, known for his pioneering work in mobile technology and artificial intelligence. He is the Founder and President of the R42 Group, a venture capital firm investing in AI and longevity companies, and an Adjunct Professor in Genetics at the Stanford School of Medicine. Ronjon has co-founded several successful companies, including Lexicus and Cellmania, and his innovations have been instrumental in advancing mobile technology. His work continues to focus on the intersection of AI and biology, aiming to create solutions for healthier aging.

Kenneth Scott is an 81-year-old biohacker and longevity enthusiast with a biological age of 18. He has a diverse background, including roles as a mathematician, economist, and aeronautical engineer in the Royal Canadian Air Force. Kenneth is also a biotech investor and real estate developer. He and his wife spend significant resources on experimental treatments to reverse aging and have invested in biotech companies focused on longevity. Kenneth is a prominent figure in the longevity community, advocating for the potential of extended human lifespan and immortality.

Kevin Caldwell is the co-founder, President, and CEO of Ossium Health, a pioneering bioengineering company focused on creating the world's first bone marrow bank for transplants. With a background in physics and economics from MIT and a JD from Harvard Law School, Kevin has also worked as an Engagement Manager at McKinsey and a Senior Investment Associate at Bridgewater Associates. His diverse experience and dedication to improving human health through innovative solutions make him a significant figure in the biotech industry.

Mark Hamalainen is a visionary scientist and entrepreneur dedicated to extending human lifespan through innovative biotechnology. As the co-founder and co-executive director of the Longevity Biotech Fellowship, he focuses on fostering a community of researchers and innovators working on breakthrough technologies to combat aging. His career has spanned from manual bench work in academia to lab automation at Synthego, and now to building the longevity movement. Mark is passionate about finding higher leverage methods to accelerate progress in the field of longevity.

Irina Conboy, PhD, is a Professor of Bioengineering at the University of California, Berkeley, where she leads groundbreaking research on aging and rejuvenation. As the head of the Conboy Laboratory, her work has advanced understanding of how aging impacts stem cells and tissues. Notable for her innovative use of heterochronic parabiosis and blood apheresis, Dr. Conboy aims to develop therapies that reverse age-related decline, promoting healthier aging and tissue regeneration to extend lifespan and improve quality of life in older adults.

Mgoes is the co-founder of BiohackerDAO, a citizen science organization dedicated to data-driven self-optimization and radical human enhancement. He advocates for a minimalist, evidence-based approach to longevity, rigorously testing interventions and eliminating those that don't show clear, consistent improvements in his biomarkers. Mgoes focuses on actions that offer significant leverage, optimizing his daily routine for maximum impact. He is passionate about combining science and community collaboration to push the boundaries of human potential.

Ari Tulla is a San Francisco-based entrepreneur and the co-founder and CEO of Elo Health, a precision nutrition service transforming food from the cause of disease to medicine. With a background as CEO of Quest Analytics and co-founder of BetterDoctor, Ari has a proven track record of leading companies through pivotal growth stages. He is also an active angel investor with a portfolio of over 50 startups, including Virta Health and Oura. Outside of work, Ari enjoys rock climbing, surfing, and spending time with his family.

Adam Marblestone is CEO of Convergent Research, an organization pioneering new models to launch focused, high-impact research projects tackling critical scientific challenges. With a deep interest in longevity, Adam previously served as Research Director for Longevity at Astera Institute and has advanced science moonshots as an Innovation Fellow at Schmidt Futures. His career includes research leadership roles at MIT, DeepMind, and Kernel, where he bridged fields like AI, neuroscience, and biotechnology. Adam’s visionary approach aims to accelerate scientific progress, including breakthroughs to extend healthspan and combat aging.

Martin Borch Jensen is the co-founder and CSO of Gordian Biotechnology, focused on developing pooled in vivo therapeutic screenings to address aging-related diseases. He has a rich background in aging biology, mitochondrial health, and neurodegenerative diseases, with key publications in Cell Metab and Nature. Jensen holds a prestigious NIH K99/R00 award and previously studied DNA repair mechanisms in aging at the National Institute on Aging. In addition to his leadership role at Gordian, he serves on multiple scientific advisory boards and co-authored a popular science book on intermittent fasting and aging.

Mike Conboy, PhD, is a leading Research Scientist at the University of California, Berkeley, specializing in aging and rejuvenation research. As a key member of the Conboy Laboratory, he collaborates with his wife, Irina, to explore how aging affects stem cells and tissues. His work on heterochronic parabiosis and blood apheresis has shed light on potential therapies to reverse age-related damage and enhance tissue repair. Dr. Conboy is dedicated to advancing methods that could significantly improve healthspan and extend the healthy human lifespan.

Justin Rebo is the co-founder and CEO of Kind Bio, a biotechnology company focused on developing innovative solutions to extend healthy human lifespans. His work involves leveraging cutting-edge technologies to create therapies that target aging and age-related diseases. Justin's vision is to revolutionize the field of longevity and improve the quality of life for people around the world.

Alice Gilman is a global leader in longevity innovation and strategic operations, with experience organizing over 80 events across 40+ countries. As a consultant and researcher in longevity labs and startups, she brings deep expertise in investor relations, brand strategy, and operational leadership. Alice co-founded Homespace, securing $500K in funding, and has driven impactful initiatives in AI, biotech, and healthspan-focused ventures. With roles spanning COO, business consulting, and founder residencies, Alice combines entrepreneurial vision and operational excellence to pioneer solutions for living longer, healthier lives.

Felix Werth is a biochemist and political advocate, best known for founding the Party for Rejuvenation Research in Germany. The party focuses on accelerating the development of regenerative medicine to extend healthy human lifespans. As the party's leader, Felix is dedicated to raising public awareness and support for rejuvenation research, aiming to prevent age-related diseases and promote longer, healthier lives.

John Martin Fischer is a Distinguished Professor of Philosophy at the University of California, Riverside, and a leading contributor to the philosophy of free will and moral responsibility. He is known for his theory of semi-compatibilism, which explores the relationship between free will and moral responsibility. Fischer has also made significant contributions to the metaphysics of death and the philosophy of religion. He has served as President of the American Philosophical Association, Pacific Division, and was elected a Fellow of the American Academy of Arts and Sciences in 2024.

Jesse Horwitz is the Co-Founder of Agora and Hubble Contacts, where he has driven innovation in the direct-to-consumer contact lens market. With a strong background in investment analysis, Jesse has previously worked at Columbia Investment Management and Bridgewater Associates. His entrepreneurial journey also includes founding Gadfly Capital. Passionate about transforming industries, he leverages his expertise in finance and strategic investment to create impactful ventures. Through his work at Agora and Hubble, Jesse continues to shape the future of health and consumer-focused innovation.

Dr. Larry Callahan, a distinguished retired chemist, has made significant contributions to global health through his pioneering work at the FDA. With a Ph.D. in Chemistry from the University of Chicago, his groundbreaking research on the B-Z DNA transition and the synthesis of non-hydrolysable analogs led to advancements in enzymology. At the FDA, Dr. Callahan was a trailblazer in HIV research, identifying the mechanisms behind HIV infectivity and the ineffectiveness of CD4-based therapies. He also spearheaded the development of the ISO 11238 standard. Now Chief Scientist at Trials of Life, he leads efforts to revolutionize drug development and clinical research transparency worldwide.

Alexandrul-Ioan Voda, DPhil, is a passionate leader in regenerative medicine, bioinformatics, and biotech. As CEO of The Cat Health Company, Alex leverages a diverse skill set combining wet-lab and computational sciences to drive advancements in biomedical research. A coding aficionado fluent in Python, R, and Bash, Alex specializes in machine learning, data structures, and algorithms. With a DPhil from the University of Oxford, he has contributed to groundbreaking work in inflammatory bowel disease genetics, aging clocks, and human health. His experience spans both academic and industry sectors, with a strong focus on innovation and scientific leadership.

Alberto Aparicio is an Assistant Professor in the Department of Bioethics and Health Humanities. He completed postdoctoral fellowships at the Global Observatory for Genome Editing at Harvard University and the Alexander von Humboldt Biological Resources Research Institute in Colombia. Dr. Aparicio holds a PhD in Science and Technology Studies from University College London and an MPhil in Technology Policy from Cambridge University. With experience in policy, academia, consultancy, and government, his research focuses on the governance of emerging biotechnology and the societal implications of bioscience, including evolving attitudes toward life and technoscience.

Ariel Zeleznikow-Johnston is a neuroscientist at Monash University, Australia, where he investigates methods for characterising the nature of conscious experiences. Ariel is also the author of "The Future Loves You: How and Why We Should Abolish Death", and has been featured in major publications like The Guardian and the BBC. His research interests range from the decline, preservation and rescue of cognitive function at different stages of the lifespan, through to comparing different people’s conscious experience of colour. By contributing to research that clarifies the neurobiological, cognitive, and philosophical basis of what it is to be a person, he hopes to accelerate the development of medical infrastructure that will help prevent him and everyone else from dying.

Akshay Sanghavi is the founder of Yuvan Research, a company focused on reversing biological age to cure chronic diseases. With over a decade of experience in epigenetics and gene regulation, Akshay has pioneered non-chemotherapy, immune-based cancer therapies and researched natural solutions to ameliorate aging-related biochemical declines. He also led innovative advancements in LED lighting technology as COO, where his team developed disruptive solutions that reduced parts by 70% and introduced the industry’s first lifetime warranty. Akshay’s work continues to push the boundaries of health and technology innovation.

Kamen Shoylev is a dual-qualified lawyer, practicing at both the Bulgarian and English Bars. As co-managing partner at New Balkans Law Office, he provides expert advice on corporate, commercial, regulatory, and IP law, focusing on cross-border issues between Bulgaria, the EU, and the UK. Kamen’s legal expertise spans corporate disputes, EU law, and intellectual property. With a keen interest in innovation and longevity, he integrates his knowledge of science, technology, and investment ethics into his work. Kamen holds a B.A. in Law from Cambridge University and is committed to advancing entrepreneurial and legal solutions globally.

Siim Land is an 8-time bestselling author, anthropologist, keynote speaker, and longevity advocate dedicated to maximizing healthy human lifespan. With over a decade of research into health, fitness, and mindset, he empowers high-performing individuals through his YouTube channel, blog, and online coaching. Combining a background in Cultural and Social Anthropology with a passion for human optimization, Siim Land delivers transformative insights into body-mind empowerment. His Amazon-bestselling books and rising video courses inspire audiences worldwide to thrive physically, mentally, and professionally.

Prof. Peter Lidsky is an expert in virology and genetics, with MS and PhD training from Moscow State University, focusing on virus-host interactions in Picornaviruses. He advanced his career at the University of Zurich, developing fluorescent imaging tools for Drosophila. At UCSF, Prof. Lidsky integrated his virology and genetics expertise, establishing a renowned research program. He is best known for developing the "pathogen control" hypothesis of aging, a pioneering framework that continues to shape his groundbreaking research on the intersection of aging, immunity, and pathogen dynamics.

Ethan Perlstein is a visionary scientist-entrepreneur dedicated to eradicating rare diseases. As Founder/CEO of Perlara PBC, the first biotech public benefit corporation, Ethan has pioneered healthspan-extending therapeutics and cures for rare metabolic disorders. He also leads Maggie's Pearl LLC, advancing precision medicines for ultra-rare conditions, and recently launched Curetopia, a groundbreaking DAO aiming to transform rare disease treatment through decentralized collaboration. With a PhD from Harvard and impactful roles at Princeton and the Reeve Foundation, Ethan blends innovation and leadership to redefine biotech’s role in global health.

Yuri Deigin is an entrepreneur, scientist, and biotech innovator with a deep focus on life sciences and longevity research. He is the co-founder and CEO of YouthBio Therapeutics, a company dedicated to developing cutting-edge gene therapies aimed at reversing aging processes at the cellular level. With a background in biotechnology, drug development, and artificial intelligence, Yuri has been at the forefront of translating scientific discoveries into practical solutions to combat age-related decline. His work is driven by a passion for advancing rejuvenation technologies to extend healthy human lifespan and improve quality of life.

Eleanor Sheekey is a dynamic scientist and communicator, blending cutting-edge research with engaging education. As a Postdoctoral Researcher at RIKEN, she explores skin aging and extracellular matrices, building on her PhD at the Cancer Research UK Cambridge Institute, where she studied p53 and cellular senescence. Creator of the Sheekey Science Show YouTube channel, Eleanor simplifies complex science for almost 50K subscribers, covering topics like longevity and CRISPR. She’s also a guest lecturer and director of Sheekey Science Solutions. Passionate about knowledge-sharing, Eleanor’s work inspires curiosity and advances understanding in biomedicine.

Jason Kelly is an entrepreneur and innovator with over a decade of experience in synthetic biology and biotechnology. He is the co-founder and CEO of Ginkgo Bioworks, a company pioneering the use of biological engineering to create sustainable solutions across industries. Jason's background is rooted in biological engineering and computational biology, with a focus on harnessing the power of living organisms to address global challenges. His work aims to revolutionize manufacturing, agriculture, and medicine by programming biology to create a more sustainable and healthier future.

Kazuma Kishida is the pioneering CEO of Dioseve, a groundbreaking biotech company revolutionizing infertility treatment by developing human eggs from iPS and ES cells. Under his leadership, Dioseve is at the forefront of creating new possibilities for couples struggling with infertility, aiming to redefine reproductive medicine. With a strong foundation in financial strategy from his tenure as a financial analyst at Houlihan Lokey, Kaz combines scientific innovation with business acumen to drive transformative advancements in biotech. Based in Tokyo, he is committed to delivering hope through science and innovation.

Dr. Keshav K. Singh, a globally recognized expert in longevity and mitochondrial science, is the founder and Chief Scientific Officer of Yuva Biosciences, a trailblazing biotech company focused on extending healthspan through mitochondrial innovation. As the Joy and Bill Harbert Endowed Chair at UAB and founding editor of Mitochondrion, Dr. Singh has authored over 100 publications and three books, earning honors like Stanford’s Top 2% Scientists and Newsweek’s Innovation Hero. A dynamic thought leader, he pioneers transformative research at the intersection of aging, health disparities, and mitochondrial genetics.

Paul Kiesow brings 35+ years of engagement in the field of anti-aging and vibrant life extension to Vitalist Bay 2025. With his emphasis on the critical role of brain preservation and health, Paul shares insights from his journey, his inspirations, strategies and successes. His work as an early member and writing contributor with the Life Extension Foundation in the 1980s and '90s led to an impactful personal plan regarding metabolic optimization, neuron protection, and whole brain health—now evidenced by recent medically evaluated cranial CT scans showing no signs of age-related decline. At 72, Paul continues to defy aging norms and is positively energized by the expectation of a vibrant extended life.

Sebastian Giwa is an entrepreneur and innovator with extensive experience in biotechnology and translational research. He is the founder of Sylvatica Biotech, a company at the forefront of developing advanced preservation technologies to enable organ banking and improve global access to transplantation. Sebastian's background spans cryobiology, tissue engineering, and regenerative medicine, with a focus on overcoming the challenges of long-term organ storage. His work aims to revolutionize healthcare by creating solutions that enhance the availability and efficiency of life-saving organ transplants worldwide.

Vladik Krupalnik, a visionary biotech entrepreneur, is the CEO, co-founder, and board member of RenewalBio, advancing groundbreaking innovations in regenerative medicine. With a diverse leadership background, including roles as COO of RenewalBio and CSO at Epeius Pharma, Vladik has spearheaded transformative work in cell and gene therapy, focusing on next-generation delivery systems for CNS therapies. As a co-inventor and board member of CatchMe Therapeutics, he drives cutting-edge solutions in oncology. His expertise spans bioinformatics, diagnostics, and translational research, making him a key strategist in biotech innovation.

Grant Fraser, M.D. is a quadruple board certified physician with each of these certifications supporting a broad scope of practice in the longevity space.  The most recent certification is Anti-Aging and Regenerative Medicine.  He practices longevity and precision primary care medicine, exclusively via telemedicine to 9 states.  As part of his practice, he has developed a sensible construct that helps to organize the items that go into a longevity medicine comprehensive consultation.

‍

Matthew Osman is an entrepreneur and AI specialist with a diverse background in finance and law. He holds a degree in Philosophy, Politics, and Economics from the University of Oxford. He co-founded Legit.ai, a life science AI startup that utilized natural language processing to streamline research and development processes. Under his leadership, Legit.ai was acquired by Clora in 2020. Matthew's work focuses on integrating AI technologies across various industries to drive innovation and efficiency.

Throughout his career, Andrew McKenzie has contributed to the understanding of brain cell type-specific gene expression and co-expression network architectures. His work aims to advance the field of neuroscience through innovative research and collaboration. Dr. McKenzie's research focuses on brain banking, ischemic alterations in the brain, and long-term preservation methods. His scholarly work emphasizes structural brain preservation, guiding the research directions at Oregon Brain Preservation, a non-profit organization.

Melissa King is a strategic management and communications executive with extensive experience in global healthcare and research policy. She is the Chief Operating Officer and a Founding Board Member of the Healthspan Action Coalition, an organization dedicated to promoting healthy aging and advancing medical research to reduce the burden of chronic diseases. Throughout her career, Melissa has been a passionate advocate for patients suffering from chronic illnesses, focusing on accelerating medical advancements and ensuring equitable access to innovative treatments. She has played a pivotal role in engaging multiple stakeholders and effectively communicating complex scientific concepts to diverse audiences.

Niklas Anzinger is an entrepreneur and investor with a focus on innovative urban development and regulatory frameworks. He is the founder and CEO of Infinita City, an organization dedicated to leveraging special regulatory zones to accelerate biomedical progress. Niklas is also the founder and general partner of Infinita VC, a venture capital firm based in the charter city of Próspera in Honduras, focusing on charter cities and alternative jurisdictions. His work creates scalable regulatory solutions that can be applied across multiple jurisdictions, fostering environments conducive to innovation and progress.

Dr. Hisham Badaruddin is a medical doctor and public health specialist with over 25 years of experience in the healthcare system. He is the founder and CEO of Bartley Clinic, a general practice in Singapore that integrates primary care with longevity medicine to make advanced healthcare more accessible. At Bartley Clinic, Dr. Hisham focuses on preventive medicine, health screening, lifestyle medicine, and modern longevity science, aiming to optimize health and extend disease-free years for his patients. Throughout his career, Dr. Hisham has held leadership roles in biopharma, healthcare insurance, and telehealth companies.

Kevin Perrott is an entrepreneur and scientist with over 15 years of experience at the intersection of biotechnology and longevity research. He is the founder and CEO of OpenCures, an organization dedicated to empowering individuals to harness the potential of self-directed health data and cutting-edge scientific insights to improve their longevity. Kevin’s background spans molecular biology, biogerontology, and bioinformatics. His work focuses on advancing personalized approaches to health optimization and developing therapies to combat the root causes of aging.